Hey, all of you with #Colon or #Rectal #Cancer. @MayoClinic we have a solution for You. https://t.co/VQ8YtYRCPY

Great talk by Dr. @NPMcKenna at the #MinnesotaSurgicalSociety2025 meeting on #ExpeditedDischarge after #ColorectalSurgery @MayoClinicSurg @DrDavidLarson

Thanks to @AmCollSurgeons and the @MayoClinic @MayoClinicSurg for seeing robotics, when <1% of cases were done this way, as an innovation that is now main stream benefiting #patients and #surgeons. @IntuitiveSurg True innovative mindsets benefit the world

Is Minimally Invasive Surgery at an Inflection Point?

Is Minimally Invasive Surgery at an Inflection Point?

September Issue: Oncological Outcomes of #NeoadjuvantChemotherapy Versus Upfront Surgery in Locally Advanced #ColonCancer : A Systematic Review, Meta-Analysis, and Sequential Analysis @RichardSassun @DrDavidLarson @JyiChengNg https://t.co/JxalBzgrDA @AMVillanoMD @SyedAAhmad5

@DrDavidLarson @escp_tweets @MayoClinic Such a great dinner together. Very grateful and proud of your friendship and mentorship.

To my friends and amazing research fellows. Thank you for sharing your brilliant minds with me. I am grateful and proud of all your accomplishments ⁦@escp_tweets⁩ #tripartite ⁦@MayoClinic⁩

Without Dr Jyi Cheng Ng @JyiChengNg #JohnHopkinsSurgery Present for F2F conversation it is never as Fun. MS Teams presence will have to do. Thank you for sharing your brilliant mind with us this AM

🌟New pub! 🚨 Impact of down-staged lateral pelvic lymph nodes on local recurrence in rectal cancer patients. Grateful to @DrDavidLarson for his mentorship & all my coauthors! https://t.co/fk9dvKgNmQ @MayoClinicSurg @JournalofGISurg

#DCRJournal Resident's Corner | Tumor Deposits in Colon Cancer: https://t.co/0ioWZoNZmY

*News Release* @CMSGov is recommending a 2.5% "efficiency adjustment" payment reduction in the proposed 2026 Medicare Physician Fee Schedule based on the assumption that surgeons are faster in completing procedures than in the past. However - a new @acsjacs Research Letter

Wow. If it makes this much difference in locally advanced colon cancer, imagine the potential survival advantage in node positive and resectable stage IV colon cancer. @EricDozoisMD @DrDavidLarson

Dr. Amit Merchea and the DOS team at Mayo Clinic Florida are exploring PIPAC—a novel chemo approach that uses a pressurized aerosol to target peritoneal metastases with better absorption and fewer side effects. https://t.co/iRXSVmLLbK

Strategy posts record Q2 2025 results & shares 2025 guidance. Q2 Result: $14B op. income, $10B net income, $32.60 EPS. FY2025 Earnings Guidance: $34B op. income, $24B net income, $80 EPS. FY2025 BTC Guidance: 30% BTC Yield, $20B BTC $ Gain.

Strategy posts record Q2 2025 results & shares 2025 guidance. Q2 Result: $14B op. income, $10B net income, $32.60 EPS. FY2025 Earnings Guidance: $34B op. income, $24B net income, $80 EPS. FY2025 BTC Guidance: 30% BTC Yield, $20B BTC $ Gain. https://t.co/qXLqZEBcqj

@MayoClinicSurg @GcZahira @MayoClinic Correct. For all #coloncancer #patients check out the practice leading care! Thanks to @RichardSassun and #TEAM @MayoClinicSurg

A study led by @MayoClinic clinicians shows that neoadjuvant chemotherapy (NAC) improves 5-year survival in locally advanced #ColonCancer. Analysis of 8 control trials supports NAC as a safe, effective alternative with high-quality evidence. Learn more: https://t.co/VTOJKOOGXl

📣📣Excited to share our publication in @AnnSurgOncol on the impact of RAS/BRAF mutations on pCR in rectal cancer in the TNT era. 🟢 Mutations associated with: ⬇️ pCR rates ⬇️ DFS Grateful to @DrDavidLarson and all co-authors! @RichardSassun @JyiChengNg @MayoClinicSurg

We’ve upgraded https://t.co/uGbtzwJ4Pu with powerful new features—including $STRD, $STRK, $STRF, and $BTC analytics, an interactive BTC Credit Model, time series charts, and downloadable data. Check it out.

Incredible story. @MayoClinic @MayoCancerCare